Ligne de temps

Selene Di Carlo
Ingénieur(e) de Recherche
06 oct. 2023
news

New publication – Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis.

Lire plus
05 oct. 2023
publication

Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis.

Lire plus
30 janv. 2023
news

New publication – Stromal regulation of the intestinal barrier

Lire plus
25 janv. 2023
publication

Stromal regulation of the intestinal barrier.

Lire plus
06 mai 2022
news

New publication – PDGFRα-induced stromal maturation is required to restrain postnatal intestinal epithelial stemness and promote defense mechanisms

Lire plus
05 mai 2022
publication

PDGFRα-induced stromal maturation is required to restrain postnatal intestinal epithelial stemness and promote defense mechanisms.

Lire plus
21 juil. 2019
project

The tumor stromal microenvironment

Lire plus
02 janv. 2018
publication

The perivascular origin of pathological fibroblasts

Lire plus
14 mai 2016
publication

B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer

Lire plus
16 juil. 2015
team

Stroma, inflammation et réparation tissulaire

Lire plus
16 avr. 2015
publication

ATM kinase sustains HER2 tumorigenicity in breast cancer

Lire plus
20 févr. 2015
publication

Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells

Lire plus
06 déc. 2012
publication

Inhibition of p85, the non-catalytic subunit of phosphatidylinositol 3-kinase, exerts potent antitumor activity in human breast cancer cells

Lire plus
29 juil. 2012
publication

Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury

Lire plus
30 juin 2009
publication

Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression

Lire plus
13 févr. 2008
publication

Induction of ErbB-3 expression by alpha6beta4 integrin contributes to tamoxifen resistance in ERbeta1-negative breast carcinomas

Lire plus